The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-Aminothiazolo[5,4-d]pyrimidin-7-yl)-N-(3-pyridyl)-piperazine-1-carboxamide ID: ALA4218639
PubChem CID: 145970081
Max Phase: Preclinical
Molecular Formula: C15H16N8OS
Molecular Weight: 356.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(N2CCN(C(=O)Nc3cccnc3)CC2)c2ncsc2n1
Standard InChI: InChI=1S/C15H16N8OS/c16-14-20-12(11-13(21-14)25-9-18-11)22-4-6-23(7-5-22)15(24)19-10-2-1-3-17-8-10/h1-3,8-9H,4-7H2,(H,19,24)(H2,16,20,21)
Standard InChI Key: FLEPMDMQZVIRIZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
7.8898 -29.6871 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8887 -30.5067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5967 -30.9156 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5950 -29.2783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3036 -29.6835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3084 -30.5067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0928 -30.7565 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.5728 -30.0877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0850 -29.4246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1807 -30.9147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5925 -28.4611 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3009 -28.0511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3004 -27.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5933 -26.8271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8850 -27.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8838 -28.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5939 -26.0099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8866 -25.6008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3020 -25.6019 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0094 -26.0111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0051 -26.8281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7117 -27.2371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4207 -26.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4187 -26.0076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7116 -25.6022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
4 11 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 1 0
17 18 2 0
17 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 356.42Molecular Weight (Monoisotopic): 356.1168AlogP: 1.42#Rotatable Bonds: 2Polar Surface Area: 113.16Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.79CX Basic pKa: 4.65CX LogP: 0.87CX LogD: 0.87Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.71Np Likeness Score: -2.04
References 1. Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R.. (2018) Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo., 61 (15): [PMID:29952567 ] [10.1021/acs.jmedchem.8b00521 ]